Related Experiment Videos

Experimental production of actinomycetoma in BALB/c mice

Infection and Immunity
|September 1, 1980
PubMed

Insights

Researchers induced chronic actinomycetoma in mice using Nocardia brasiliensis, creating a model to study this fungal infection and test new treatments. This experimental model shows persistent lesions and aids in developing better therapeutic agents.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Animal Models

Background:

  • Actinomycetoma is a chronic fungal infection often associated with agricultural environments.
  • Understanding the pathogenesis and developing effective treatments for actinomycetoma remain significant challenges.

Purpose of the Study:

  • To establish a reproducible experimental model of actinomycetoma in BALB/c mice.
  • To investigate the disease progression and characteristics of Nocardia species infections.
  • To provide a platform for evaluating potential chemotherapeutic agents.

Main Methods:

  • Subcutaneous inoculation of live Nocardia brasiliensis, Nocardia asteroides, and Nocardia caviae into the hind footpads of BALB/c mice.
  • Use of Freund incomplete adjuvant to enhance disease induction.
  • Monitoring lesion development, persistence, and presence of grains over six months.
  • Comparison of infections induced with adjuvant versus saline suspensions.

Main Results:

  • Nocardia brasiliensis successfully induced persistent chronic actinomycetoma lesions in mice, with varying incubation periods based on inoculum size.
  • Nocardia asteroides and Nocardia caviae caused localized lesions that healed spontaneously but led to peritoneal dissemination.
  • Grains were recovered from N. brasiliensis and N. caviae lesions, but not N. asteroides.
  • Adjuvant significantly accelerated the onset of actinomycetoma compared to saline suspensions.

Conclusions:

  • The experimental model effectively replicates chronic actinomycetoma caused by Nocardia brasiliensis.
  • This model allows for detailed study of disease progression and is suitable for therapeutic trials.
  • Further research using this model can lead to the development of novel chemotherapeutic strategies for actinomycetoma.

Related Concept Videos